We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Sanofi offers research, development, manufacturing and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new G enzyme.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

AbbVie is a biopharmaceutical company that develops pharmaceuticals and medical devices. The company provides products and services to therapeutic areas including immunology, oncology, neuroscience, eye care,virology, women's health, and gastroenterology advancing treatments across various therapeutic areas.

Novocol Pharma is a CDMO based in Cambridge, Ontario, Canada. With over 40 years of competence, our team of 600+ employees and modern facilities provide customer value with specialization in sterile injectable cartridge manufacturing. Our capabilities include process scale up, drug development, analytical services, technology transfer and low to high volume commercial manufacturing of biologic and small molecule products. We offer combination product assembly services and, through our affiliate organization, Duoject Medical Systems (www.duoject.com), we design your innovative drug delivery devices. Our global regulatory approvals span USA, Canada, Europe, Middle East and Asia. If your drug development pipeline includes cartridge-based pharmaceuticals, Novocol Pharma should be your trusted partner. We are a proud member of the Septodont group of companies. www.septodont.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Pharmaceutical-technology.com is one of a network of 30+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year. As part of GlobalData, we have access to over 1bn data points including companies, deals, projects and forecasts and trends. Leading data informs and supports our industry leading content. With expertise spanning more than 80 markets globally and driven by 800+ award-winning journalists, researchers, and analysts, we connect you with the information that makes and breaks businesses every day. Combined with our award-winning targeting technology built into our network of websites, we offer a unique end-to-end marketing solution combining insight, creativity, and cutting-edge AI-technology. Our marketing solution allows clients to identify, target and engage with prospects using access and ownership of our 30+ B2B media websites and their large sector specific audiences. With more reach, data targeting and first-party data than any other partner, we produce world-class campaigns for our clients. For more details on our technology-driven marketing solution visit www.globaldatamarketingsolutions.com

Developer of an AI drug development platform designed to empower pharma with ai technology for treatments and enhanced research and development. The company's platform is an adaptive quantitative reasoning engine that integrates multi-source datasets from genomic and clinical records to operational and policy data,and offers features like AI-driven research, AI agents, and context-aware reasoning, helping leaders in life sciences to make decisions that revolutionize pharmaceutical drug discovery for critical diseases like cancer, diabetes, and more.

Coalesce seeks out, evaluates, authenticates and implements innovative emerging technologies to conquer major scientific barriers and speed up the creation of better medicines, diagnostics and advanced materials. For more than two decades, Coalesce has worked in conjunction with Pharmaceutical and Biotech Organizations, Technology, Services and Medical Device Providers, Technology Investors, Governments, Charitable Foundations, Regulatory Agencies and World Health Agencies to tackle major community-wide challenges. Hundreds of breakthrough technologies have been identified, adapted and implemented for the pharmaceutical, biotech and chemical industries. Please join us in conquering major scientific barriers affecting your organization and industry, and participate in the accelerated development of better medicines, diagnostics and materials. - Coalesce identifies major barriers & implements community-validated solutions - Coalesce specifies the optimum embodiments of existing and emerging technologies to overcome major challenges - Coalesce introduces validated solutions to all those who can benefit Our mission is simple: To conquer scientific barriers and speed the creation of better medicines, diagnostics and beneficial materials by putting powerful new technologies, services and procedures into the hands of the scientists who can make the most difference.

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia

eQuantX Pharma Analytics Solution is a leading global service provider to Pharmaceutical, Medical devices, Biotechnology and Life sciences companies and supports them to develop, launch, and commercialize their products successfully. Our core services are Competitive Intelligence, Market Access Support, Pricing and Reimbursement, Market Assessment & Strategic Insight, Clinical Trial analytics, Advance Analytics, HEOR and RWE Generation, Competitive Intelligence, Pricing Analytics, Asset Valuation & Forecasting (Cashflow, NPV, eNPV, IRR), AI & Machine Learning-based Digital Health, and Data Analytics Platform Development. Creating intelligence across all aspects of the pharmaceutical value chain through analytics, extensive domain expertise and transformative technology are the motives behind each service offering we provide to our clients. eQuantX delivers powerful insights with agility and empowers clients to accelerate their clinical development and commercialization of innovative medical treatments to improve patient healthcare outcomes. Privacy remained a top priority for the company; hence we use various privacy-enhancing tools to protect and safeguard all-project-related information. Specialties:  Business Research  Asset Valuation and Forecasting  Competitive Intelligence  Market Access, Pricing and Reimbursement  HEOR and Real-World Evidence  Data Analytics and Innovative Market Models Our Strengths:  Extensive In-House Research Capabilities and Therapy Areas Expertise  Adding Value Proposition through Continuous Innovation and Productization  Global Reach and Strong Regional Presence  Developing Customized Data Analytics Platforms using AI/ML  Continuous Onsite-offsite Support to Global Clients via FTEs & Ad-hoc Set-ups Please get in touch with us for more details: corporate@equantx.com

InnoGlobal Technology (formerly Innopharma Technology) empowers manufacturers to embrace the transformative power of Industry 4.0 through cutting-edge automation and digitalization solutions. We go beyond traditional approaches to deliver deeper process understanding, enhanced quality adherence, and ultimately, improved efficiency and sustainability. As part of the InnoGlobal group of companies, we are committed to guiding industry, government, funders, and educational institutions toward the human-centric and sustainable future of Industry 5.0. Driven by a dynamic team of engineers, scientists, and software developers, InnoGlobal Technology is committed to helping manufacturers achieve their digital transformation goals and unlock the full potential of Industry 4.0 and contribute to the human-centric, sustainable vision of Industry 5.0.

Fuera Emerging Technologies Inc. specializes in delivering innovative industrial automation and engineering services that transform manufacturing and production processes. We focus on advanced robotics, industrial IoT, smart factory solutions, and process optimization to help our clients achieve operational efficiency, enhanced productivity, and sustainable growth. Our expertise lies in integrating cutting-edge automation systems, predictive maintenance technologies, and custom-engineered solutions to ensure seamless operations across a variety of industries. At Fuera, we are dedicated to empowering businesses with the tools and technologies they need to stay ahead in the evolving landscape of Industry 4.0. Partner with Fuera and unlock the full potential of automation to drive your business forward.

Information Services *1. Comprehensive Product Range* - Offering a vast selection of pharmaceuticals, over-the-counter medications, and medical supplies. - Specializing in brand-name and generic medications to meet diverse healthcare needs. *2. Quality Assurance* - Adhering to stringent quality control measures to ensure the highest standards of safety and efficacy. - Partnering with reputable manufacturers and suppliers to maintain product integrity. *3. Efficient Distribution* - Utilizing state-of-the-art logistics to ensure timely and reliable delivery. - Providing nationwide coverage with fast shipping options to meet urgent medical needs. *4. Customer Support* - Dedicated customer service team available to assist with orders, inquiries, and technical support. - Offering personalized account management to streamline procurement processes for clients. *5. Competitive Pricing* - Committed to offering competitive pricing to help healthcare providers manage costs effectively. - Providing flexible payment options and volume discounts for bulk purchases. *6. Educational Resources* - Offering access to the latest medical research, drug information, and healthcare trends. - Hosting webinars and training sessions for healthcare professionals to stay informed and compliant. *7. Regulatory Compliance* - Ensuring all products meet regulatory requirements and industry standards. - Maintaining transparency and accountability in all business practices. *8. Innovation and Technology*- Leveraging advanced technology for inventory management, order processing, and customer interactions. - Investing in innovative solutions to enhance service delivery and operational efficiency. *9. Environmental Responsibility*Implementing sustainable practices in our operations to minimize environmental impact. Promoting eco-friendly products & packaging solutions. *10. Community Engagement* Participating in community outreach programs to promote public health and wellness.

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Pharma Tech Outlook is a leading print and digital publication pioneering in bringing forth real-world solutions, news, product trends and solutions to help business leaders surge ahead in the pharma space. With comprehensive insights from established business leaders, we equip organizations to gain a competitive edge and successfully navigate the changing industry landscape.

Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlocking greater value per program and ultimately accelerate access to new treatments for patients. 2025 CNBC Disruptor 50 2025 Fierce 15 Award 2024 Endpoints 11 Award

Luminari accelerates drug development using our Digital Twin AI technologies to reduce clinical trial costs, errors, and delays with advanced AI and blockchain technologies.

Real-World Research. Delivered with Scientific Rigour and Operational Clarity. At Evalus AI, we help pharmaceutical, biotech, and medical device companies run smarter late-phase studies. Whether it's Real-World Evidence (RWE), PMS, registries, or long-term observational trials, our platform makes complex research simpler, faster, and fully compliant. Evalus offers a modular suite of validated tools tailored for late-phase research and real-world settings. Our platform enables sponsors to streamline data collection, ensure regulatory alignment, and reduce operational complexity. Our product includes: • Electronic Data Capture (EDC) • Clinical Trial Management System (CTMS) • Electronic Patient-Reported Outcomes (ePRO) • Electronic Trial Master File (eTMF) • eConsent and Remote Patient Monitoring All modules are built in accordance with 21 CFR Part 11, ICH-GCP, HIPAA, EU-GDPR, and ISO 27001 standards. Our technology-enabled workflows accelerate data capture and improve data quality while keeping study teams inspection-ready at all times. Why Choose Evalus? • Purpose-built for late-phase and RWE studies • Modular, interoperable digital platform • Built by regulatory and scientific experts • Strong compliance foundation • India-based operations, globally scalable execution From protocol design to publication, Evalus brings together regulatory precision, scientific clarity, and operational flexibility, helping our clients turn post-approval data into meaningful, measurable insights.

Pharma IT delivers competitive, experienced, and professional IT and Drug Development Consultants to the Pharma, Biotech and Medical Device Industries. We're on a mission to raise the standards of consulting in our industry by challenging the way it is usually done. We believe that attracting the best pharma consultants is more important than a costly sales force and a lavish administration. We believe that staying up to date with the latest trends and regulations by educating and certifying our consultants is more important than a big, fancy office in an expensive building. We believe in spending time with the customer, so we have removed time-consuming, off-site internal meetings. Instead we meet online and use cloud services for collaboration. We are ready and able to help your team reach your goals and remain in compliance, so don't hesitate to reach out! Pharma IT is a ProductLife Group Company.

Indivi is a TechBio company developing multi-modal deep phenotyping technologies and derived decision-making biomarkers as drug development tools for neurological diseases for instance in the form of sensor-derived measurements generated from smartphone-based assessments of cognition and motion. Indivi is committed to developing future-proof and transformative digital endpoints as deep phenotyping instruments to accelerate and de-risk drug development in neurodegenerative disorders such as Parkinson’s disease, multiple sclerosis, Alzheimer’s disease and related dementias. Indivi is nurturing a unique symbiotic intersection between expert in-house knowledge and experience in clinical development, data science, signal processing engineering, and advanced analytics including computational intelligence. Through end-to-end collaborative endeavours with biopharmaceutical companies, Indivi is poised to continue its growth to improve the probability of technical and regulatory success in neuroscience drug development.